ArticleExperimental and therapeutic medicine2021

TRIB3 promotes oral squamous cell carcinoma cell proliferation by activating the AKT signaling pathway.

Peng Shen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.